What Is Leriche Syndrome? Causes, Symptoms, and Treatment

Leriche Syndrome is a specific manifestation of peripheral arterial disease (PAD) that affects the body’s largest artery, the aorta, as it supplies blood to the lower body. The condition involves a significant blockage, or occlusion, occurring in the lower abdominal aorta and the common iliac arteries, which branch off the aorta. This severe restriction of blood flow to the pelvis and lower limbs represents a serious vascular condition that requires prompt medical attention.

The Aortic Occlusion and Its Underlying Cause

The blockage occurs specifically at the aortic bifurcation, the point where the aorta divides to form the two common iliac arteries that descend into the legs. This high-level obstruction severely compromises the blood supply to both lower extremities and pelvic organs, leading to the characteristic symptoms of the syndrome.

The cause of this arterial occlusion is advanced atherosclerosis, characterized by the buildup of fatty plaques within the artery walls. Over time, these plaques harden and narrow the vessel, eventually leading to complete closure. This progressive process is accelerated by several health factors that promote widespread arterial damage.

Risk factors include a history of smoking, which causes direct harm to the inner lining of blood vessels and promotes plaque formation. Uncontrolled hypertension and diabetes mellitus also significantly contribute to the rapid progression of atherosclerosis throughout the arterial system. Managing these underlying conditions is essential for preventing and slowing the progression of this disease.

Recognizing the Classic Triad of Symptoms

The most recognizable clinical presentation of this syndrome is the classic triad of three symptoms. This triad helps physicians distinguish Leriche Syndrome from other forms of peripheral arterial disease that involve blockages lower down in the legs. The unique location of the obstruction high in the pelvis dictates these symptoms.

The first component is claudication, a cramping pain or aching sensation that occurs predictably with physical exertion and is relieved by rest. This pain is typically felt bilaterally in the muscles of the hips, buttocks, and thighs, rather than just the calves. The pain corresponds directly to the muscle groups receiving insufficient blood flow during activity due to the aortoiliac blockage.

The second feature of the triad is the absence or marked diminution of the femoral pulses. Because the blockage occurs just before the arteries become the femoral arteries, the pulse wave is severely dampened or completely abolished below the level of the occlusion. This lack of palpable pulsation is typically found in the main arteries of the upper legs.

Finally, the third characteristic symptom, which primarily affects male patients, is erectile dysfunction. The internal iliac arteries, which branch off the common iliac arteries, supply blood to the pelvic organs required for an erection. When the main aortoiliac flow is restricted, the blood supply to the penis is insufficient, leading to the inability to achieve or maintain an erection. The presence of all three of these signs suggests the diagnosis.

Tools Used for Diagnosis

The evaluation for this condition begins with a physical examination, which includes checking for the absent or weakened femoral pulses. A physician may also listen for an abnormal swooshing sound, known as a bruit, over the abdomen or groin, indicating turbulent blood flow through a narrowed artery. These initial findings guide the need for more specialized non-invasive testing.

The Ankle-Brachial Index (ABI) compares the blood pressure measured at the ankle to the blood pressure measured in the arm. A low ABI value, typically less than 0.9, suggests reduced blood flow to the lower extremities and provides objective evidence of PAD. Duplex ultrasonography is another non-invasive tool that uses sound waves to visualize blood flow and measure its velocity within the arteries.

Cross-sectional imaging techniques are then used to map the arterial occlusion, which is necessary for planning treatment. Computed Tomography Angiography (CTA) or Magnetic Resonance Angiography (MRA) provide detailed, three-dimensional images of the entire aortoiliac segment. These images allow the medical team to precisely visualize the degree of plaque buildup and the length of the blockage, guiding the choice between endovascular and open surgical intervention.

Intervention and Management Strategies

Treatment for Leriche Syndrome involves a comprehensive approach that starts with modifying the underlying risk factors. Smoking cessation is the most effective intervention for slowing the progression of atherosclerosis and improving long-term outcomes. Medications like antiplatelet agents, such as aspirin, are prescribed to reduce the risk of clot formation within the narrowed arteries.

Statin medications are administered to manage cholesterol levels and stabilize existing atherosclerotic plaques. Patients are encouraged to participate in supervised exercise programs, which can help improve walking distance and overall quality of life, even before surgical intervention. These lifestyle and medical modifications are essential for managing this condition.

For more severe or symptomatic blockages, revascularization procedures are necessary to restore proper blood flow to the legs. Endovascular techniques, such as balloon angioplasty and stenting, involve inserting a catheter to widen the blocked artery and place a mesh tube to keep it open. These less invasive procedures are generally reserved for shorter or less complex blockages.

When the occlusion is long or involves a complete blockage of the aortic bifurcation, the treatment is often an open surgical procedure called an Aortobifemoral bypass graft. This operation involves surgically connecting a synthetic graft, typically a Y-shaped tube, from the healthy aorta above the blockage to the femoral arteries in both groins. The graft effectively bypasses the diseased segment and is often performed to prevent the complication of critical limb ischemia.